Asian Oncol Nurs.  2018 Jun;18(2):94-103. 10.5388/aon.2018.18.2.94.

Effects of a Medication Management Program for Cancer Patients Receiving Oral Chemotherapy

• Han S
• Kim S
• Lee Y

• KMID: 2429027
• DOI: http://doi.org/10.5388/aon.2018.18.2.94

Abstract

PURPOSE
The purpose of this study was to assess the effects of a medication management program on oral chemotherapy patients.
METHODS
A nonequivalent control group ppretest-posttest design was used. Participants were 60 cancer patients (intervention group: 30, control group: 30). The medication management program was provided for 6 weeks. Collected data were analyzed using the SPSS/WIN 21.0 program.
RESULTS
Although there were no statistically significant differences, scores of self-efficacy (t=−0.12, p=.902), knowledge (t=0.62, p=.537), medication adherence (t=0.51, p=.610), and staff satisfaction (t=1.44, p=.156) were higher in the experimental group than in the control group.
CONCLUSION
There was no significant difference in self-efficacy, knowledge, symptom experience, medication adherence and staff satisfaction. This can be explained by both groups having already received initial instruction concerning basic care when they started to receive chemotherapy. Considering the positive outcome of the medication management program, a specialist nursing effort is needed to improve symptoms and medication adherence. Furthermore, a medication counseling hotline is needed to support the medical staff.

Keyword

Medication Adherence; Medication Therapy Management; Mouth; Neoplasms

MeSH Terms

Counseling
Drug Therapy*
Hotlines
Humans
Medical Staff
Medication Adherence
Medication Therapy Management
Mouth
Nursing
Specialization

Reference

1. National Cancer Information Center (KR). Causes of death statistics [Internet]. Available from. http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parmTabId=M_01_01. [Accessed May 25, 2016].

2. Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, et al. NCCN task force report: oral chemotherapy. J Natl Compr Canc Netw. 2008; 6(Suppl 3):S1–14.

3. Banna GL, Collovà E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, et al. Anticancer oral therapy: emerging related issues. Cancer Treat Rev. 2010; 36:595–605.

4. Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014; 10:162–7.

5. Spoelstra SL, Given BA, Given CW, Grant M, Sikorskii A, You M, et al. An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: an exploratory study. Cancer Nurs. 2013; 36:18–28.

6. Foulon V, Schöffski P, Wolter P. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg. 2011; 66:85–96.

7. Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev. 2013; 39:610–21.

8. Barclay TR, Hinkin CH, Castellon SA, Mason KI, Reinhard MJ, Mar-ion SD, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007; 26:40–9.

9. Shin JH, Kim GS, Lee JH, Oh SJ. The effects of periodic reminding interventions on medication adherence, self-efficacy, and pain for home-based lung cancer patients. J Korean Clin Nurs Res. 2013; 19:443–54.

10. Lee YH, Jeong IS. Factors influencing medication adherence to oral anticancer drugs. Asian Oncol Nurs. 2013; 13:201–9.

11. Choi JS. Adherence to oral anticancer drugs in elderly cancer patients [dissertation]. Seoul: Seoul National Univ.;2012.

12. Lee ER. Patient compliance with oral anticancer drug medication and factors affecting compliance with medication [dissertation]. Seoul: Seoul National Univ.;2006.

13. Kim JH. A model for medication adherence in cancer patients receiving oral chemotherapy [dissertation]. Seoul: Chung-Ang Univ.;2012.

14. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59:56–66.

15. Seo MA. A structural equation model explaining medication compliance of schizophrenia. Korean J Nurs Query. 2002; 11:138–67.

16. Spoelstra SL, Given CW. Assessment and measurement of adherence to oral antineoplastic agents. Semin Oncol Nurs. 2011; 27:116–32.

17. Regnier Denois V, Poirson J, Nourissat A, Jacquin JP, Guastalla JP, Chauvin F. Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncolo-gists. Eur J Cancer Care (Engl). 2011; 20:520–7.

18. Lee YH. The development and evaluation of motivational interviewing based medication management program for cancer patients taking oral anticancer agents [dissertation]. Busan: Pusan Univ.;2015.

19. Lee HJ. Factors affecting medication compliance of hypertensive patients [dissertation]. Seoul: Dankook Univ.;2002.

20. Kwon YS. A study on the effect of information on knowledge level and anxiety in cancer patients receiving chemotherapy [dissertation]. Seoul: Yonsei Univ.;1988.

21. Samarel N, Leddy SK, Greco K, Cooley ME, Torres SC, Tulman L, et al. Development and testing of the symptom experience scale. J Pain Symptom Manage. 1996; 12:221–8.

22. Park JH. Patterns and related factors of fatigue during radiotherapy in patients with breast cancer [dissertation]. Seoul: Yonsei Univ.;2002.

23. La Monica EL, Oberst MT, Madea AR, Wolf RM. Development of a patient satisfaction scale. Res Nurs Health. 1986; 9:43–50.

24. Choi EJ, Jang IS, Hwang JH, Kang YA, Kim SR, Nho JH, et al. Patient satisfaction with advanced practice nurse in a tertiary hospital. J Korean Clin Nurs Res. 2015; 21:335–46.

25. Branch RM. Instructional design: the ADDIE approach. New York, NY: Springer;2009.

26. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977; 84:191–215.

27. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch In-tern Med. 2007; 167:540–50.

28. Boucher J, Lucca J, Hooper C, Pedulla L, Berry DL. A structured nursing intervention to address oral chemotherapy adherence in patients with non-small cell lung cancer. Oncol Nurs Forum. 2015; 42:383–9.

29. Spoelstra SL, Given CW, Sikorskii A, Coursaris CK, Majumder A, DeKoekkoek T, et al. Feasibility of a text messaging intervention to pro-mote self-management for patients prescribed oral anticancer agents. Oncol Nurs Forum. 2015; 42:647–57.